Abstract
The majority of children with cerebral palsy (CP) have feeding difficulties and are especially prone to malnutrition. The early involvement of a multidisciplinary team should aim to prevent malnutrition and provide adequate nutritional support. Thorough nutritional assessment, including body composition, should be a prerequisite for the nutritional intervention. As in typically-developed children nutritional support should start with dietary advice and the modification of oral feeding, if safe and acceptable. However, for prolonged feeding, in the presence of unsafe swallowing and inadequate oral intake, enteral nutrition should be promptly initiated and early gastrostomy placement should be evaluated and discussed with parents/caregivers. Gastrointestinal problems (oropharyngeal dysfunction, gastroesophageal disease, and constipation) in children with CP are frequent and should be actively detected and adequately treated as they can further worsen the feeding process and nutritional status.
Cerebral palsy (CP) comprises of a heterogeneous group of early-onset, non-progressive, neuromotor disorders which affect the developing fetal or infant brain [1]. The latest systematic review and meta-analysis, published in early 2013, estimated the prevalence of CP to be 2.11 per 1,000 live births and as high as 59.18 per 1,000 live births among neonates weighing less than 1,500 g. The prevalence has remained constant over the recent decade, despite the increased survival of at-risk preterm infants [2]. The life expectancy of children with CP has gradually improved and thus, the prevalence and consequences of feeding difficulties are on the rise [3]. Based on data from the North American Growth in CP Project, 58% of children with moderate to severe CP had feeding difficulties, in which 23% were severe [4]. Feeding disorders play an important role in the development of malnutrition, documented in 29%–46% of CP children. The prevalence of undernutrition increased with older age, lower intelligence quotients, and more severe neurological impairment [5]. Beside growth failure, the most evident consequence of malnutrition, other include decreased cerebral function and reduced potential for development, impaired immune function, impaired circulation with poor wound healing, diminished respiratory muscle strength [3].
The importance of malnutrition and the need for nutritional management have been recognized by many societies. Most recently, the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) published guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment [6].
The aim of this article was to review the literature on the assessment of nutritional status and nutritional management in children with CP.
Nutritional assessment in children with CP would ideally be performed by a multidisciplinary team consisting of a physician (preferably pediatric gastroenterologist), dietitian, nurse, speech and language therapist, physical therapist, occupational therapist, and psychologist [6]. Early integration of a multidisciplinary team should aim to identify children at risk for malnutrition and to provide nutritional management before malnutrition develops. As with any nutritional assessment, it should begin with a detailed clinical history and physical examination, followed by anthropometrics (methods assessing body composition), and laboratory methods [6].
Physicians should obtain information regarding the etiology and severity of the child's neurological impairment, as well as comorbidities and prescribed medications [7]. Information relating the child's motor ability should be objectified using the Gross Motor Function Classification System (GMFCS) and combined with information relating to psychomotor development, communication skills, as well as functional vision. The inability to communicate, together with moderate to severe cognitive impairment, may affect a child's ability to convey thirst, hunger and satiety, as well as to express preferences regarding food texture, flavor, and any discomfort during feeding. Other factors which can negatively influence are the visual impairment, scoliosis and contractures causing poor positioning [7]. Furthermore, antiepileptic drugs can reduce alertness and cause a variety of gastrointestinal adverse effects, such as heartburn, nausea, vomiting, gum problems, diarrhea, and constipation [8]. Suboptimal dosing with antiepileptic drugs and frequent seizures can negatively influence the feeding, as well [7].
It is very important to properly assess nutritional intake. To increase the accuracy, 24-hour food recall and/or a 3-day food diary can be used to provide the necessary information. Dietitians are advised to be cautious when interpreting diaries since families may overestimate the amounts consumed by overlooking spillage or vomiting and underestimate the time required for feeding [7]. Since feeding and nutritional problems are more likely to occur in children with severe motor disabilities [9], full assessment in such cases necessitates the evaluation of oral motor skills and swallowing by other professionals, such as speech and occupational therapists [7]. The best way to gain insight into the feeding process is either to have meal time at home video recorded by parents or to observe feeding in a hospital/outpatient setting.
In the physical examination, special attention should be given to the inspection of the skin and peripheral circulation. Poor wound healing, the presence of decubitus ulcers, cold extremities, prolonged capillary refill time, and signs of micronutrient deficiencies can indicate malnutrition [6].
Anthropometric assessment is a widely used method for assessing growth and nutritional status. In children with CP, measurement can be difficult and the references commonly used in pediatrics tend to misinterpret malnutrition in this specific group of patients [10].
Even weight measurements often require special scales, like wheelchair scales, sitting scales, and hoist scales [11]. Height measurement is even more challenging. Standing height or supine length can be used in children who can stand or lay down straight. However, in children who are unable to stand upright due to scoliosis, limb contractures, and spasticity, alternative measurements for the height assessment should be segmental lengths, such as knee-heel length, tibia length, and ulnar length, assessed by sliding calipers [6]. Special equations or charts can then be used to calculate the standing height. The anthropometric measurements have proper value if plotted into adequate growth charts. Several CP-specific growth charts containing estimated weight-for-age or height-for-age percentiles have been created. Most recently, in 2011, Brooks et al. [12] published clinical growth charts for children with CP, stratified according to gender and GMFCS level. However, these charts show how children with CP are growing, not necessarily how they should grow. Therefore, ESPGHN recommends the use of growth charts for typically-developed children to assess growth in children with CP [6].
Regardless, nutritional status in children with CP should not be estimated solely by weight and height measurements. It should also depend on follow-up and body composition assessments [6].
According to the ESPGHAN recommendation, children with neurological impairments should have their body composition assessed [6] and different methods have been used to assess it. The measurement often referred to as the criterion standard for the assessment of body composition is whole-body dual-energy x-ray absorptiometry (DXA) [13]. DXA can detect known alterations in body composition in children with CP, such as increased total body water, decreased fat-free mass, and decreased bone mineral density [14]. However, DXA scanning can often be challenging in children with CP due to severe scoliosis, joints contractures, and poor positioning. Other methods used to determine body composition include deuterium oxide (D2O) dilution, underwater weighing, and bioelectrical impedance (BIA). Several studies have evaluated the role of BIA in the body composition assessment and found that BIA estimated body composition well compared to standard methods, such as DXA and D2O dilution [1516]. Thus far, even more cost-effective and widely-available methods are the measurement of skinfold thicknesses, primarily the triceps and subscapular skinfold thicknesses. The results can then be evaluated by different equations, mainly the Slaughter equation for typically-developed children [17]. Though, these equations do not take into account the different body compositions of children with CP, in whom more body fat is stored centripetally and, consequently, so their total body fat percentage can be underestimated [13]. In order to improve the accuracy of the Slaughter equation, Gurka et al. [18] developed coefficients that correct for sex, race, size, pubertal status, and GMFCS level, minimizing the errors.
There is no single laboratory marker representing adequate or inadequate nutritional status. Studies evaluating the micronutrient status of children with CP found that deficiencies for iron, zinc, copper, vitamin D, carnitine, folic acid, and vitamin B12 were common and their incidence ranged between 10% and 55% [1920]. The assessment of micronutrient status, as part of the assessment of nutritional status in children with CP, therefore, is strongly encouraged [6].
As already mentioned, the determination of nutritional status in CP children can be challenging. Therefore, ESPGHAN recommends the use of 1 or more red flag warning signs, including physical signs of undernutrition (like pressure sores and poor peripheral circulation), weight for age z score <−2, triceps skinfold thickness in the <10th centile for age and sex, mid-upper arm circumference or muscle area in the <10th percentile, faltering weight, and/or failure to thrive [6].
There are no appropriate specific recommendations for assessing the energy requirements in children with CP [5]. Neurological impairment in children with CP varies greatly, and therefore, nutritional requirements in those children cannot be generalized. Children with CP who can walk require more energy for walking, while those dependent on a wheelchair require 60% to 70% of the energy required by typically-developed children [2122]. Therefore, nutritional requirements should be assessed individually. The best predictor of energy needs has been found to be fat-free mass [23]. Ideally, indirect calorimetry can be used to assess such needs [5], however, in regular clinical practice, this is difficult, time-consuming, and in many places, not available. Thus, most clinicians use the Schofield equation and dietary reference intake for typically-developed children [6]. These references should only be a starting point and regular follow-up is needed in order to tailor future nutritional intervention [6].
The most appropriate mode of nutritional intervention should be determined based on the patient's age, clinical condition, gastrointestinal function, safety and feasibility of oral intake, dietary habits, and costs [24]. Although oral feeding is preferred, it should be advised if nutritionally sufficient, safe, stress-free, and if feeding time does not exceed 3 to 4 hours per day [6]. Optimization of oral intake can be done by increasing the energy content through the addition of energy-rich foods and textural changes [25]. In cases where nutritional requirements cannot be met orally, the use of enteral nutrition should be considered [24]. It needs to be emphasized that enteral tube feeding should before undernutrition develops if the child is at high-risk for malnutrition [6]. The choice of enteral formula should be based on the child's age, energy requirements, and mode of enteral access (Table 1). Blenderized or pureed food are often preferred by caregivers as they perceive benefits from giving food in its natural state and providing food eaten by other family members [26]. There is limited evidence showing that the prevalence of vomiting and use of acid-suppressive agents were significantly decreased or gagging/retching was reduced following Nissen fundoplication after blenderized tube feeding was initiated [2728]. However, there is a concern regarding the nutritional adequacy and safety of home-prepared tube food [29]. Therefore, the ESPGHAN position paper advises caution and surveillance when blenderized diets are used for enteral feeding [6].
In children with CP, enteral nutrition is usually required for prolonged times, therefore, many centers offer early gastrostomy placement. Although early gastrostomy placement is frequently refused by parents in the beginning, a systematic review showed that this strategy significantly improved weight and height gain, overall nutritional status, subcutaneous fat stores, ease of feeding and, importantly, caregiver satisfaction [30]. Most frequently, gastrostomy tubes are placed endoscopically as percutaneous endoscopic gastrostomies (PEGs). However, children with CP often have significant scoliosis and PEG cannot be safely placed because transillumination of the stomach is often not visible. In these cases, a laparoscopic gastrostomy or laparoscopically-assisted PEG can be safe alternatives. Laparoscopic gastrostomies or laparoscopically-assisted PEGs have been shown to significantly lower the rate of major complications in these patients [31].
In some patients, gastrostomy feeding is not tolerated and post-pyloric or jejunal feeding can be recommended as an alternative. These cases include the presence of severe gastric motility disorder, severe gastroesophageal reflux disease (GERD) which cannot be managed by anti-reflux surgery, or in patients at very high-risk for aspiration [32]. A jejunal tube (nasojejunal tube or jejunal tube introduced through a gastrostomy or surgical transcutaneous jejunostomy) should be positioned distal to the Treitz ligament to prevent retrograde filling of the stomach [624].
Enteral tube feeding in the stomach should be administered as a bolus feeding if tolerated, however, children with high-caloric needs or with poor volume tolerance could benefit from a combination of overnight continuous feeding with boluses during the day [56]. Jejunal feeding should be provided as continuous iso-osmolar feeding [6].
The most prevalent gastrointestinal difficulty in children with CP is oropharyngeal dysfunction (OPD). OPD, including oropharyngeal dysphagia and oral motor dysfunction, is characterized by the presence of disturbances in 1 or more of the 3 phases of swallowing (oral, pharyngeal, and esophageal) [6]. The prevalence of OPD in children with CP is high, up to 90% [33], and it is more frequent in younger children and children with poorer gross motor function (GMFCS III to V) [34]. The possible clinical signs of OPD include sialorrhea, coughing, wet breathing, gagging, choking, and alteration in appetite. The assessment of OPD includes direct observation of meal times by appropriately trained professionals (speech therapist, physicians, nurses, dietitians, or others) [6]. Several scoring systems have been proposed for the assessment of OPD, but the Schedule Oral Motor Assessment (SOMA) and the Dysphagia Disorders Survey (DDS) are the tools are most widely used to support clinical decision-making [35]. The SOMA is mainly a test of oral phase dysfunction and is intended for use in children with CP aged between 10 and 42 months, while the DDS evaluates oral, pharyngeal, and esophageal phases and is designed for children with developmental disabilities between 3 and 13 years of age [35]. Finally, videofluoroscopy (VFS) is the key tool for the assessment of OPD [6]. It can be used to identify reduced lip closure, inadequate bolus formation, residue in the oral cavity, delayed triggering of pharyngeal swallow, reduced larynx elevation, coating on the pharyngeal wall, delayed pharyngeal transit time, multiple swallows, discoordinate pharyngeal motility, and silent aspiration [3637]. In cases of high suspicious of an abnormal pharyngeal phase of swallowing, and when VFS founding are normal, high-resolution esophageal manometry can be recommended [6]. Management of OPD in children with CP requires a multidisciplinary approach. Although evidence regarding the treatment of OPD is limited, management should aim to optimize oral intake in cases where intake has been proven safe. Interventions, according to ESPGHAN, include speech and language interventions and/or the consistency of feeding modifications [6]. The highest rate of improvement was seen in children in whom only the oral phase of swallowing was affected, while a recently published study found low GMFCS to be an additional positive factor [34].
Up to 70% of children with CP suffer from GERD [38]. Due to the very high frequency of GERD and fragility of children with CP in whom diagnostic tests are difficult to perform, a trial of proton pump inhibitors (PPIs) with careful clinical follow-up is acceptable according to ESPGHAN recommendations [6].
However, persistent symptoms do require additional diagnostic tests, including esophageal pH-metry, multichannel intraluminal impedance, and/or upper endoscopy, to evaluate GERD. In some children with persistent vomiting, additional diagnostic workup (including barium swallow and abdominal ultrasound) can be recommended in order to exclude other problems causing intestinal obstruction [6].
The main treatment for GERD in children with CP is PPIs but that treatment can be combined with lifestyle changes. Lifestyle changes consist of adequate positioning and certain dietary modifications, including the thickening of liquid formula and selection of whey-based, instead of casein-based, enteral formula [39]. Therapy with PPIs effectively reduces acid reflux and, therefore, treats esophagitis, however it does not have an effect on the volume and the number of the reflux episodes [40]. Therefore, although not routinely prescribed, the use of prokinetic agents, primarily baclofen, can be recommended for children in whom other pharmacological treatments have failed [641]. Frequently, fundoplication needs to be considered in children with GERD which cannot be pharmacologically controlled [641]. There is always a question as to whether fundoplication should routinely be performed in children with CP who require gastrostomy placement. This question was mainly raised by some studies that found that PEG placement increased GERD episodes [42], however, the majority of data from other studies did not confirm this association [4344]. Therefore, the combined procedure should be recommended only in selected patients.
Another very frequent gastrointestinal symptom in children with CP is constipation, at a prevalence of 26% to 74% [945]. The causes of constipation in disabled children include neuromuscular factors, such as intestinal motility disorders, hypotonia, skeletal muscle discoordination, and skeletal deformities, combined with prolonged immobility of the child, as well as nutritional factors, such as low fiber and poor fluid intake and pharmacological factors (e.g., anticholinergics and opiates have negative effects on intestinal and colonic transit time) [46]. Diagnosis and treatment should be the same as for typically-developed children [6]. Although more than 50% of children with CP chronically use laxatives, they are less responsive to treatment than typically-developed children so the dose needs to be adjusted [47]. Since fiber and fluid intake is inadequate in 53% of children with neurological impairments [48], the increase of daily fiber and fluid intake can be an additional strategy [6]. In cases of refractory constipation, anterograde continence enemas have been reported to be effective treatment options [49], but should be recommended only in cautiously-selected patients.
The prevalence of feeding difficulties and undernutrition is still high in children with CP. Early involvement of a multidisciplinary team should aim to detect children at risk for malnutrition and provide adequate nutritional support in order to prevent undernutrition. Thorough nutritional assessment, including body composition, should be a prerequisite for the nutritional intervention. Individual approaches, as well as early enteral nutrition, if required, should be applied and gastrointestinal problems should be recognized in a timely fashion and treated.
References
1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007; 109:8–14.
2. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013; 55:509–519.
3. Sullivan PB. Nutrition and growth in children with cerebral palsy: setting the scene. Eur J Clin Nutr. 2013; 67:Suppl 2. S3–S4.
4. Fung EB, Samson-Fang L, Stallings VA, Conaway M, Liptak G, Henderson RC, et al. Feeding dysfunction is associated with poor growth and health status in children with cerebral palsy. J Am Diet Assoc. 2002; 102:361–373.
5. Marchand V, Motil KJ. NASPGHAN Committee on Nutrition. Nutrition support for neurologically impaired children: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2006; 43:123–135.
6. Romano C, van Wynckel M, Hulst J, Broekaert I, Bronsky J, Dall'Oglio L, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr. 2017; 65:242–264.
7. Andrew MJ, Parr JR, Sullivan PB. Feeding difficulties in children with cerebral palsy. Arch Dis Child Educ Pract Ed. 2012; 97:222–229.
8. Jahromi SR, Togha M, Fesharaki SH, Najafi M, Moghadam NB, Kheradmand JA, et al. Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients. Seizure. 2011; 20:343–346.
9. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford feeding study. Dev Med Child Neurol. 2000; 42:674–680.
10. Araújo LA, Silva LR. Anthropometric assessment of patients with cerebral palsy: which curves are more appropriate? J Pediatr (Rio J). 2013; 89:307–314.
11. Stevenson RD, Conaway M, Chumlea WC, Rosenbaum P, Fung EB, Henderson RC, et al. Growth and health in children with moderate-to-severe cerebral palsy. Pediatrics. 2006; 118:1010–1018.
12. Brooks J, Day S, Shavelle R, Strauss D. Low weight, morbidity, and mortality in children with cerebral palsy: new clinical growth charts. Pediatrics. 2011; 128:e299–e307.
13. Sullivan P. Measurement of body composition should become routine in nutritional assessment of children with cerebral palsy. Dev Med Child Neurol. 2015; 57:793–794.
14. Stallings VA, Cronk CE, Zemel BS, Charney EB. Body composition in children with spastic quadriplegic cerebral palsy. J Pediatr. 1995; 126:833–839.
15. Oeffinger DJ, Gurka MJ, Kuperminc M, Hassani S, Buhr N, Tylkowski C. Accuracy of skinfold and bioelectrical impedance assessments of body fat percentage in ambulatory individuals with cerebral palsy. Dev Med Child Neurol. 2014; 56:475–481.
16. Liu LF, Roberts R, Moyer-Mileur L, Samson-Fang L. Determination of body composition in children with cerebral palsy: bioelectrical impedance analysis and anthropometry vs dual-energy x-ray absorptiometry. J Am Diet Assoc. 2005; 105:794–797.
17. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988; 60:709–723.
18. Gurka MJ, Kuperminc MN, Busby MG, Bennis JA, Grossberg RI, Houlihan CM, et al. Assessment and correction of skinfold thickness equations in estimating body fat in children with cerebral palsy. Dev Med Child Neurol. 2010; 52:e35–e41.
19. Kalra S, Aggarwal A, Chillar N, Faridi MM. Comparison of micronutrient levels in children with cerebral palsy and neurologically normal controls. Indian J Pediatr. 2015; 82:140–144.
20. Sánchez-Lastres J, Eirís-Puñal J, Otero-Cepeda JL, Pavón-Belinchón P, Castro-Gago M. Nutritional status of mentally retarded children in northwest spain: II. Biochemical indicators. Acta Paediatr. 2003; 92:928–934.
21. Bandini LG, Schoeller DA, Fukagawa NK, Wykes LJ, Dietz WH. Body composition and energy expenditure in adolescents with cerebral palsy or myelodysplasia. Pediatr Res. 1991; 29:70–77.
22. Samson-Fang L, Bell KL. Assessment of growth and nutrition in children with cerebral palsy. Eur J Clin Nutr. 2013; 67:Suppl 2. S5–S8.
23. Walker JL, Bell KL, Stevenson RD, Weir KA, Boyd RN, Davies PS. Relationships between dietary intake and body composition according to gross motor functional ability in preschool-aged children with cerebral palsy. Ann Nutr Metab. 2012; 61:349–357.
24. Braegger C, Decsi T, Dias JA, Hartman C, Kolacek S, Koletzko B, et al. Practical approach to paediatric enteral nutrition: a comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr. 2010; 51:110–122.
25. Bell KL, Samson-Fang L. Nutritional management of children with cerebral palsy. Eur J Clin Nutr. 2013; 67:Suppl 2. S13–S16.
26. Bobo E. Reemergence of blenderized tube feedings: exploring the evidence. Nutr Clin Pract. 2016; 31:730–735.
27. Gallagher K, Flint A, Mouzaki M, Carpenter A, Haliburton B, Bannister L, et al. Blenderized enteral nutrition diet study: feasibility, clinical, and microbiome outcomes of providing blenderized feeds through a gastric tube in a medically complex pediatric population. JPEN J Parenter Enteral Nutr. 2018; 42:1046–1060.
28. Pentiuk S, O'Flaherty T, Santoro K, Willging P, Kaul A. Pureed by gastrostomy tube diet improves gagging and retching in children with fundoplication. JPEN J Parenter Enteral Nutr. 2011; 35:375–379.
29. Vieira MM, Santos VF, Bottoni A, Morais TB. Nutritional and microbiological quality of commercial and homemade blenderized whole food enteral diets for home-based enteral nutritional therapy in adults. Clin Nutr. 2018; 37:177–181.
30. Samson-Fang L, Butler C, O'Donnell M. AACPDM. Effects of gastrostomy feeding in children with cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol. 2003; 45:415–426.
31. Baker L, Beres AL, Baird R. A systematic review and meta-analysis of gastrostomy insertion techniques in children. J Pediatr Surg. 2015; 50:718–725.
32. Dormann AJ, Huchzermeyer H. Endoscopic techniques for enteral nutrition: standards and innovations. Dig Dis. 2002; 20:145–153.
33. Reilly S, Skuse D, Poblete X. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy: a community survey. J Pediatr. 1996; 129:877–882.
34. Benfer KA, Weir KA, Bell KL, Ware RS, Davies PS, Boyd RN. Oropharyngeal dysphagia and cerebral palsy. Pediatrics. 2017; 140:e20170731.
35. Benfer KA, Weir KA, Boyd RN. Clinimetrics of measures of oropharyngeal dysphagia for preschool children with cerebral palsy and neurodevelopmental disabilities: a systematic review. Dev Med Child Neurol. 2012; 54:784–795.
36. Wright RE, Wright FR, Carson CA. Videofluoroscopic assessment in children with severe cerebral palsy presenting with dysphagia. Pediatr Radiol. 1996; 26:720–722.
37. van den Engel-Hoek L, Erasmus CE, van Hulst KC, Arvedson JC, de Groot IJ, de Swart BJ. Children with central and peripheral neurologic disorders have distinguishable patterns of dysphagia on videofluoroscopic swallow study. J Child Neurol. 2014; 29:646–653.
38. Reyes AL, Cash AJ, Green SH, Booth IW. Gastrooesophageal reflux in children with cerebral palsy. Child Care Health Dev. 1993; 19:109–118.
39. Khoshoo V, Zembo M, King A, Dhar M, Reifen R, Pencharz P. Incidence of gastroesophageal reflux with whey- and casein-based formulas in infants and in children with severe neurological impairment. J Pediatr Gastroenterol Nutr. 1996; 22:48–55.
40. Turk H, Hauser B, Brecelj J, Vandenplas Y, Orel R. Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children. World J Pediatr. 2013; 9:36–41.
41. Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018; 66:516–554.
42. Thomson M, Rao P, Rawat D, Wenzl TG. Percutaneous endoscopic gastrostomy and gastro-oesophageal reflux in neurologically impaired children. World J Gastroenterol. 2011; 17:191–196.
43. Razeghi S, Lang T, Behrens R. Influence of percutaneous endoscopic gastrostomy on gastroesophageal reflux: a prospective study in 68 children. J Pediatr Gastroenterol Nutr. 2002; 35:27–30.
44. Toporowska-Kowalska E, Gębora-Kowalska B, Jabłoński J, Fendler W, Wąsowska-Królikowska K. Influence of percutaneous endoscopic gastrostomy on gastro-oesophageal reflux evaluated by multiple intraluminal impedance in children with neurological impairment. Dev Med Child Neurol. 2011; 53:938–943.
45. Park ES, Park CI, Cho SR, Na SI, Cho YS. Colonic transit time and constipation in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2004; 85:453–456.
46. Elawad MA, Sullivan PB. Management of constipation in children with disabilities. Dev Med Child Neurol. 2001; 43:829–832.
47. Pashankar DS, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediatr. 2001; 139:428–432.